【通化金马与宣武医院签署战略合作 推进阿尔茨海默病新药临床与脑卒中管线布局】上证报中国证券网讯记者8月24日从通化金马获悉，公司近日与首都医科大学宣武医院签署全方位战略合作协议。双方将聚焦神经退行性疾病、脑血管疾病两大领域，围绕已上市1类新药琥珀酸安维吖啶片的临床价值深化与脑卒中领域创新药管线布局，开展多项临床与基础研究合作项目。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.